A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease depression multimorbidities.
H2020-SC1-2019-Two-Stage-RTD
Duration:
1/1/2020 - 31/12/2024
Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma.
HORIZON-MISS-2021-CANCER-02
Duration:
1/1/2023 - 31/12/2026
Laser digital transfer of 2D materials enabled photonics: from the lab 2 the fab.
HORIZON-EIC-2021-TRANSITIONOPEN-01
Duration:
1/10/2022 - 30/9/2025
STRATEGY-CKD - System omics to
unravel the gut-kidney axis
in Chronic Kidney Disease.
H2020-MSCA-ITN-2019
Duration:
1/2/2020 - 31/1/2024
Early Detection of cancer onset based on sensing field cancerization
at the organ level.
H2020-MSCA-ITN-2020
Duration:
1/1/2021 - 31/12/2024
Ongoing Projects
HARMONIzation and intergrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome(pSS) towards improved stratification, treatment and health policy making.
The CURE project (full title “Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma” is proposing a phage therapy that could control the immune dysregulation of the disease and may eventually be able to cure it. CURE receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767015.
Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease".
